DermACELL: Human Acellular Dermal Matrix Allograft A Case Report.

Area of Science:

• Regenerative Medicine
• Wound Healing
• Diabetic Foot Complications

Background:

• Diabetic foot ulcers are a significant complication of diabetes mellitus.
• Wagner grade 3 ulcers indicate deep tissue involvement and risk of limb loss.
• Previous ulceration and osteomyelitis in the contralateral limb highlight the patient's high risk.

Observation:

• A 56-year-old insulin-dependent diabetic woman presented with a 3-week history of a Wagner grade 3 right heel ulcer.
• The ulcer exhibited moderate drainage and odor.
• The patient had a history of ulceration and osteomyelitis in the other leg.

Findings:

• A comprehensive treatment approach was employed, including hospitalization, surgical intervention, intravenous antibiotics, and vacuum-assisted closure.
• A novel room temperature, sterile, human acellular dermal matrix (DermACELL) was utilized as a graft.
• Successful wound healing was achieved, leading to limb salvage and restoration of daily activities.

Implications:

• This case highlights the potential of human acellular dermal matrices in managing complex diabetic foot ulcers.
• DermACELL offers a promising alternative treatment option for limb salvage in high-risk diabetic patients.
• Further research into acellular dermal matrices could advance diabetic foot ulcer management strategies.